Published in Ann Thorac Surg on July 01, 2007
Adverse effects of hemorrhagic shock resuscitation with stored blood are ameliorated by inhaled nitric oxide in lambs*. Crit Care Med (2013) 1.60
CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.28
Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.17
NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am J Respir Cell Mol Biol (2008) 1.13
DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines. Eur J Immunol (2009) 1.02
Beneficial effects of inhaled NO on apoptotic pneumocytes in pulmonary thromboembolism model. Theor Biol Med Model (2014) 0.83
Inflammatory response and pneumocyte apoptosis during lung ischemia-reperfusion injury in an experimental pulmonary thromboembolism model. J Thromb Thrombolysis (2015) 0.81
The beneficial effects of inhaled nitric oxide in patients with severe traumatic brain injury complicated by acute respiratory distress syndrome: a hypothesis. J Trauma Manag Outcomes (2008) 0.81
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation (2009) 3.75
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med (2002) 3.17
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Central cannulation is safe in acute aortic dissection repair. J Thorac Cardiovasc Surg (2006) 2.98
Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol (2004) 2.62
Early outcomes using the Florida sleeve repair for correction of aortic insufficiency due to root aneurysms. Ann Thorac Surg (2009) 2.24
RIFLE criteria for acute kidney injury in aortic arch surgery. J Thorac Cardiovasc Surg (2007) 2.17
Transdifferentiation of ciliated cells during repair of the respiratory epithelium. Am J Respir Cell Mol Biol (2005) 2.12
Predicted risk of mortality models: surgeons need to understand limitations of the University HealthSystem Consortium models. J Am Coll Surg (2009) 2.10
Does the Society of Thoracic Surgeons risk score accurately predict operative mortality for patients with pulmonary hypertension? J Thorac Cardiovasc Surg (2012) 2.09
Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg (2002) 1.91
Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol (2006) 1.80
S-nitrosothiols signal hypoxia-mimetic vascular pathology. J Clin Invest (2007) 1.74
Intrathoracic vacuum-assisted management of persistent and infected pleural spaces. Ann Thorac Surg (2010) 1.74
Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function. J Thorac Cardiovasc Surg (2012) 1.73
Primary payer status affects mortality for major surgical operations. Ann Surg (2010) 1.69
Do you need to clamp a patent left internal thoracic artery-left anterior descending graft in reoperative cardiac surgery? Ann Thorac Surg (2009) 1.63
Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement. Catheter Cardiovasc Interv (2013) 1.53
Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg (2009) 1.53
High spatial resolution magnetic resonance imaging of cystic adventitial disease of the popliteal artery. J Vasc Surg (2010) 1.52
Is mitral valve repair superior to replacement in elderly patients? Ann Thorac Surg (2008) 1.52
Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia. Radiology (2004) 1.51
Sleep deprivation does not affect operative results in cardiac surgery. Ann Thorac Surg (2004) 1.51
Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg (2004) 1.50
Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-alpha during pulmonary ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol (2007) 1.48
Is off-pump coronary artery bypass grafting superior to conventional bypass in octogenarians? J Thorac Cardiovasc Surg (2010) 1.47
Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg (2013) 1.45
Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping. Ann Thorac Surg (2006) 1.44
Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J Immunol (2004) 1.43
Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg (2007) 1.42
Replacement of the proximal aorta adds no further risk to aortic valve procedures. Ann Thorac Surg (2007) 1.40
Caring for the residents: the view of two program directors. Ann Thorac Surg (2004) 1.38
Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev (2004) 1.37
Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med (2011) 1.35
CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.28
Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. J Thorac Cardiovasc Surg (2005) 1.22
Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res (2008) 1.19
Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival. J Thorac Cardiovasc Surg (2012) 1.18
Endoscopic versus open saphenous vein harvest for femoral to below the knee arterial bypass using saphenous vein graft. J Vasc Surg (2006) 1.18
Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2009) 1.17
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg (2011) 1.17
Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model. J Thorac Cardiovasc Surg (2011) 1.16
Nitric oxide, a mediator of inflammation, suppresses tumorigenesis. Cancer Res (2004) 1.15
Outcomes of surgical aortic valve replacement in high-risk patients: a multiinstitutional study. Ann Thorac Surg (2011) 1.14
The role of adenosine A2A receptor signaling in bronchiolitis obliterans. Ann Thorac Surg (2009) 1.13
Upregulation of hypoxia-induced mitogenic factor in compensatory lung growth after pneumonectomy. Am J Respir Cell Mol Biol (2004) 1.13
NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am J Respir Cell Mol Biol (2008) 1.13
Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans development. J Heart Lung Transplant (2010) 1.12
Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog (2011) 1.12
Mitral repair is superior to replacement when associated with coronary artery disease. Ann Surg (2004) 1.11
Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2004) 1.11
Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. J Thorac Cardiovasc Surg (2011) 1.11
Hospital procedure volume should not be used as a measure of surgical quality. Ann Surg (2012) 1.09
Does reperfusion injury still cause significant mortality after lung transplantation? J Thorac Cardiovasc Surg (2009) 1.09
The effect of surgeon volume on mortality for off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg (2012) 1.08
Adenosine A₂A agonist improves lung function during ex vivo lung perfusion. Ann Thorac Surg (2011) 1.07
A simplified approach to degenerative disease: triangular resections of the mitral valve. Ann Thorac Surg (2007) 1.07
Cardiac injury during resternotomy does not affect perioperative mortality. J Am Coll Surg (2008) 1.07
Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker. Ann Thorac Surg (2011) 1.07
The impact of coronary artery endarterectomy on outcomes during coronary artery bypass grafting. J Card Surg (2011) 1.07
Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol (2002) 1.06